Korean J Perinatol.  2013 Sep;24(3):127-132. 10.14734/kjp.2013.24.3.127.

Recent Advances between Prenatal Inflammatory Response and Prematurity Associated Complications

• Sung TJ

• KMID: 2280929
• DOI: http://doi.org/10.14734/kjp.2013.24.3.127

Abstract

Infant who is less than a gestational age of 37 weeks, called premature baby, is born earlier and hence all organs are immature. Nowadays several studies showed that long-term outcomes of premature babies were dependent on the postnatal conditions or level of NICU care. However, there is growing body of evidence implicating infection during the prenatal periods as important contributors to the risk of adverse outcome in this high-risk population. Postnatal inflammations are characterized by the presence of marked release of inflammatory mediators; elevated proinflammatory cytokine levels (IL-1, IL-6, IL-8, TNF-alpha), C-reactive protein, myeloperoxidase, intercellular adhesion molecule-1, matrix metalloproteinase are reported in preterm infants with prenatal inflammation. Moreover, premature-associated morbidities such as bronchopulmonary dysplasia, periventricular leukomalacia, nectrotizing enterocolitis, sepsis, and retinopathy of pretmaturity are more often in that condition. In the future, studies should be continued on intrauterine inflammation together with postnatal inflammation and strategies to reduce the rates of infection with possible drugs in these vulnerable infants are needed.

Keyword

Prenatal; Postnatal; Inflammation; Premature

MeSH Terms

Bronchopulmonary Dysplasia
C-Reactive Protein
Enterocolitis
Gestational Age
Humans
Infant
Infant, Newborn
Infant, Premature
Inflammation
Intercellular Adhesion Molecule-1
Interleukin-6
Interleukin-8
Leukomalacia, Periventricular
Peroxidase
Sepsis
C-Reactive Protein
Intercellular Adhesion Molecule-1
Interleukin-6
Interleukin-8
Peroxidase

Reference

1). Thomas W., Speer CP. Chorioamnionitis: important risk factor or innocent bystander for neonatal outcome? Neonatology. 2011. 99:177–87.

2). Leviton A., Hecht JL., Allred EN., Yamamoto H., Fichorova RN., Dammann O. Persistence after birth of systemic inflammation associated with umbilical cord inflammation. J Reprod Im-munol. 2011. 90:235–43.

3). O'Shea T., Allred E., Dammann O,Hirtz D., Kuban K., Paneth N, et al. The ELGAN study of the brain and related disorders in extremely low gestational age newborns. Early Hum Dev. 2009. 85:719–25.

4). Dammann O., Leviton A., Gappa M., Dammann CE. Lung and brain damage in preterm newborns, and their association with gestational age, prematurity subgroup, infection/inflammation and long term outcome. BJOG. 2005. 112(Suppl 1):4–9.

5). Goldberg RL., Hauth JC., Andrews WW. Intrauterine infection and preterm delivery. N Eng J Med. 2000. 342:1500–7.

6). Holzman C., Lin X., Senagore P., Chung H. Histologic chorioamnionitis and preterm delivery. Am J Epidemiol. 2007. 166:786–94.

7). Salafia CM., Weigl C., Silberman L. The prevalence and distribution of acute placental inflammation in uncomplicated term pregnancies. Obste Gynecol. 1989. 73:383–9.

8). Riggs JW., Blanco JD. Pathophysiology, diagnosis, and management of intraamniotic infection. Semin Perinatol. 1998. 22:251–9.

9). Dong Y., St Clair PJ., Ramzy I., Kagan-Hallet KS., Gibbs RS. A microbiologic and clinical study of placental inflammation at term. Obstet Gynecol. 1987. 70:175–82.

10). Sampson JE., Theve RP., Blatman RN., Shipp TD., Bianchi DW., Ward BE, et al. Fetal origin of amniotic fluid polumorphonu-clear leukocytes. Am J Obstet Gynecol. 1997. 176:77–81.

11). CW Choi. Fetal inflammatory response syndrome and neonatal outcome. Korean J Perinatol. 2007. 18:214–21.

12). Watterberg KL., Demers LM., Scott SM., Murphy S. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics. 1996. 97:210–5.

13). Kramer BW., Kallapur S., Newham J., Jobe AH. Prenatal inflammation and lung development; Semin Fetal Neonatal Med. 2009. 14:2–7.

14). Goldenberg RL., Andrews WW., Faye-Petersen OM., Cliver SP., Goepfert AR., Hauth JC. The Alabama preterm birth study: corticosteroids and neonatal outcomes in 23- to 32- week newborns with various markers of intrauterine infection. Am J Obstet Gynecol. 2006. 195:1020–4.

15). Yoon BH., Romero R., Kim KS., Park JS., Ki SH., Kim BI, et al. A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia. Am J Obstet Gynecol. 1999. 181:773–9.

16). Hutton LC., Castillo-Melendez M., Smythe GA., Walker DW. Microglial activation, macrophage infiltration and evidence of cell death in the fetal brain after uteroplacental administration of lipopolysaccharide in sheep in late gestation. Am J Obstet Gynecol. 2008. 198:e1–11.

17). Adams-Chapman I., Stoll BJ. Neonatal infection and longterm neurodevelopmental outcome in the preterm infant. Curr Opin Inf Dis. 2006. 19:290–7.

18). Leviton A., Allred EN., Kuban KC., Hecht JL., Onderdonk AB., O'Shea TM, et al. Microbiologic and histologic characteristics of the extremely preterm infant's placental predict white matter damage and later cerebral palsy. The ELGAN study. Pediatr Res. 2010. 67:95–101.

19). van Vliet EO., de Kieviet JF., Oosterlaan J., van Elburg RM. Perinatal infections and neurodevelopmental outcome in very preterm and very low-birth-weight infants: a meta-analysis. JAMA Pediatr. 2013. 167:662–8.

20). Tauscher MK., Berg D., Brockmann M., Seidenspinner S., Speer CP., Groneck P. Association of histologic chorioamnionitis, increased levels of cord blood cytokines, and intracerebral hemorrhage in preterm neonates. Biol Neonate. 2003. 83:166–70.

21). Lee J., Dammann O. Perinatal infection, inflammation, and retinopathy of prematurity. Semin Fetal Neonatal Med. 2012. 17:26–9.

22). Silveira RC., Fortes Filho JB., Procianoy RS. Assessment of the contribution of cytokine plasma levels to detect retinopathy of prematurity in very low birth weight infants. Invest Oph-thalmol Vis Sci. 2011. 52:1297–301.

23). Sung TJ. Ureaplasma infections in preterm infants: recent information regarding the role of Ureaplasma species as neonatal pathogens. Korean J Pediatr. 2010. 53:989–93.

24). Hintz SR., Kendrick DE., Stoll BJ., Vohr BR., Fanaroff AA., Donovan EF, et al. Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis. Pediatrics. 2005. 115:696–703.

25). Caplan MS., Sun XM., Hsueh W., Hageman JR. Role of platelet activation factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis. J Pediatr. 1990. 116:960–4.

26). Romero R., Savasan ZA., Chaiworapongsa T., Berry SM., Kusanovic JP., Hassan SS, et al. Hematologic profile of the fetus with systemic inflammatory response syndrome. J Perinat Med. 2011. 40:19–32.

27). Mestan K., Yu Y., Matoba N., Cerda S., Demmin B., Pearson C, et al. Placental inflammatory response is associated with poor neonatal growth: preterm birth cohort study. Pediatrics. 2010. 125:e891–8.

28). Gover A., Chau V., Miller SP., Brant R., McFadden DE., Poskitt KJ, et al. Prenatal and postnatal inflammation in relation to cortisol levels in preterm infants at 18 months corrected age. J Perinatol. 2013. 33:647–51.